Loading
Latest filing published 10 Aug 2017 for Tetra Bio-Pharma Inc., €4,734.
Edward Miller discloses dealings in Tetra Bio-Pharma Inc. to SEDI. Between 13 April 2017 and 10 August 2017, the trades on record add up to 9 filings.
On the market, this insider has only ever bought: 9 purchases, €31k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The median purchase comes to €4,248. No cluster: in 8 purchases, no other insider of the company bought within 30 days.
The record was last updated on 10 August 2017 with an open-market purchase (€4,734) in Tetra Bio-Pharma Inc. The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations